EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática

Elizabeth Guadalupe Sánchez-González, Fernanda Rosales Pedraza, Brian Javier Llaca García, José Antonio Maza Larrea, Vicente Jesús Hernández-Abad

Latin american journal of clinical sciences and medical technology · 17.03.2026 · 8 (1) · 38-49

DOI: 10.34141/ljcs8012358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, erschienen am 17.03.2026. Verfasst von Elizabeth Guadalupe Sánchez-González und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in childhood. Current chemotherapy regimens have substantially increased survival; however, they are associated with a high burden of adverse drug reactions (ADRs), particularly in the pediatric population.

Objective

To critically analyze the patterns, frequencies, and severity of ADRs reported in the treatment of ALL in the Mexican pediatric population. The study aims to identify the most frequent ADRs per drug, variability in incidence according to protocols and regions, and the limitations and gaps within the national pharmacovigilance system. Materials and Methods. A systematic review was conducted following the PRISMA 2020 guidelines. International (PubMed / MEDLINE, Scopus, Cochrane) and regional (SciELO, LILACS) scientific databases were consulted, along with pharmacovigilance databases (VigiBase - WHO, FDA, EMA, COFEPRIS) for studies published between 2010-2024. Inclusion criteria were: Mexican pediatric population (

Zitieren

APA

Sánchez-González, E. G., Pedraza, F. R., García, B. J. L., Larrea, J. A. M., & Hernández-Abad, V. J. (2026). Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática. Latin american journal of clinical sciences and medical technology, 8(1), 38-49. https://doi.org/10.34141/ljcs8012358

Vancouver

Sánchez-González EG, Pedraza FR, García BJL, Larrea JAM, Hernández-Abad VJ. Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática. Latin american journal of clinical sciences and medical technology. 2026;8(1):38-49. doi:10.34141/ljcs8012358

BibTeX
@article{SnchezGonzlez2026,
  author = {Sánchez-González, Elizabeth Guadalupe and Pedraza, Fernanda Rosales and García, Brian Javier Llaca and Larrea, José Antonio Maza and Hernández-Abad, Vicente Jesús},
  title = {Reacciones adversas asociadas al tratamiento de la leucemia linfoblástica aguda en población pediátrica mexicana: revisión sistemática},
  journal = {Latin american journal of clinical sciences and medical technology},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {38--49},
  doi = {10.34141/ljcs8012358}
}
Kostenlos starten →